Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 13, 2026, 3:31 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1993–2016 of 13,940 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Control Trial Clear all

Conditions: Orthopedic Disorder, Humerus Fracture, Shoulder Arthroplasty, Reverse Shoulder Replacement
Interventions: Physical Therapy; Other
Lead sponsor: University of Virginia; Other
Eligibility: 50 Years to 85 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Molluscum Contagiosum
Interventions: Benzoyl peroxide, Adapalene Gel; Drug
Lead sponsor: University of Oklahoma; Other
Eligibility: 1 Year to 14 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Sjogren's Syndrome
Interventions: tofacitinib, Placebo; Drug · Other
Lead sponsor: National Institute of Dental and Craniofacial Research (NIDCR); NIH
Eligibility: 18 Years to 75 Years
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: HIV Infection
Interventions: Text reminders, counseling, and link coordination, Standard of care - control arm; Behavioral
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years and older
Enrollment: 381 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 2
States / cities: Chapel Hill, North Carolina • Fort Worth, Texas

Conditions: Autoimmune Disease, Infertility, Premature Ovarian Failure
Interventions: Not listed
Lead sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); NIH
Eligibility: 18 Years to 39 Years · Female only
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1992 – 2011
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Diabetes Mellitus, Type 2
Interventions: Multicomponent online program, Breath meter, Text messages, Diet-appropriate foods and cookbooks; Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: HIV Prevention, Sexually Transmitted Infections (STI), Preexposure Prophylaxis (PrEP), Incarceration, Hepatitis C Virus (HCV), Substance Use Disorder (SUD)
Interventions: Mobile Enhanced Prevention Support (MEPS), Control; Behavioral · Other
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years to 59 Years · Male only
Enrollment: 318 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2029
U.S. locations: 3
States / cities: Oakland, California • Riverside, California

Conditions: Fibromyalgia
Interventions: pregabalin, placebo; Drug
Lead sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 740 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2006
U.S. locations: 89
States / cities: Little Rock, Arkansas • Fresno, California • La Jolla, California + 76 more

Conditions: Crohn's Disease
Interventions: Adalimumab, Adalimumab PRN, Placebo; Drug
Lead sponsor: Peter Higgins; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Labor Pain
Interventions: Not listed
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years to 40 Years · Female only
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Muscle Spasticity
Interventions: Virtual Reality; Device
Lead sponsor: Gillette Children's Specialty Healthcare; Other
Eligibility: 4 Years and older
Enrollment: 49 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Saint Paul, Minnesota

Conditions: Acute Coronary Syndrome
Interventions: Polypill; Combination Product
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 1,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2030
U.S. locations: 4
States / cities: Dallas, Texas

Conditions: Metastatic Prostate Cancer
Interventions: creatine monohydrate, Placebo, Home-based, telehealth; Dietary Supplement · Other · Behavioral
Lead sponsor: University of Utah; Other
Eligibility: 18 Years and older · Male only
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Spinal Cord Injuries, Pain, Chronic, Spinal Cord Injury, Acute
Interventions: Hypnosis enhanced cognitive behavioral therapy, Pain Education; Behavioral
Lead sponsor: University of Washington; Other
Eligibility: 16 Years to 85 Years
Enrollment: 88 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Pre Diabetes, Postpartum Disorder
Interventions: Semaglutide Pen Injector [Ozempic], Placebo semaglutide pen injector; Drug
Lead sponsor: Woman's; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 102 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: Ischemic Heart Disease, Hopelessness, Physical Activity, Motivation, Social Support, Covid19
Interventions: Motivational social support from nurse, Motivational social support from nurse with additional support from significant other, Attention control; Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older
Enrollment: 224 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Grand Rapids, Michigan

Conditions: Violence Prevention, Built Environment
Interventions: Not listed
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years to 65 Years
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Abscess
Interventions: Incision and drainage, Trimethoprim/Sulfamethoxazole (Bactrim), Placebo; Procedure · Drug
Lead sponsor: Wake Forest University; Other
Eligibility: 6 Months to 18 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Dysplasia, Congenital Hip
Interventions: Tranexamic Acid, Placebo; Drug
Lead sponsor: Hospital for Special Surgery, New York; Other
Eligibility: 12 Years to 45 Years
Enrollment: 89 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 1
States / cities: New York, New York

Conditions: Obesity
Interventions: Healthy Family Foundations, Standard of Care; Behavioral · Other
Lead sponsor: Penn State University; Other
Eligibility: 18 Years to 60 Years
Enrollment: 825 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Nellis Air Force Base, Nevada

Conditions: Meibomian Gland Dysfunction (Disorder)
Interventions: localized heat therapy; Device
Lead sponsor: Sight Sciences, Inc.; Industry
Eligibility: 22 Years and older
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 1
States / cities: Brecksville, Ohio

Conditions: Breast Cancer, Cognitive Impairments
Interventions: Arm 1: Computerized Cognitive Training-Global Stimulation Games, Arm 2: Computerized Cognitive Training-Neuroplasticity Games; Behavioral
Lead sponsor: NRG Oncology; Other
Eligibility: 18 Years to 100 Years
Enrollment: 386 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 673
States / cities: Anchorage, Alaska • Fairbanks, Alaska • Gilbert, Arizona + 483 more

Conditions: Brain Metastases
Interventions: Gamma Tile-Surgically Targeted Radiation Therapy (STaRT), Stereotactic Radiation Therapy; Device · Radiation
Lead sponsor: GT Medical Technologies, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 230 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2029
U.S. locations: 37
States / cities: Phoenix, Arizona • Little Rock, Arkansas • Jacksonville, Florida + 28 more

Conditions: Asthma
Interventions: Wee Wheezers; Behavioral
Lead sponsor: Montefiore Medical Center; Other
Eligibility: 2 Years to 9 Years
Enrollment: 188 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2013
U.S. locations: 1
States / cities: The Bronx, New York

Search by objective public record fields.

Early Versus Delayed Rehabilitation After Reverse Total Shoulder Arthroplasty for Proximal Humerus Fracture

MC RCT - BPO vs Adapalene

Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Primary Sjogren's Syndrome

Evaluation of Behavioral Intervention for HIV Positive Prisoners in NC and TX

Steroid Therapy in Autoimmune Premature Ovarian Failure

Web-Delivered Interventions for Blood Sugar Control for Individuals With Type 2 Diabetes

California MEPS Hub

A Controlled Pregabalin Trial In Fibromyalgia

Calprotectin-Directed Humira® Maintenance Therapy (CADHUM)

Comparison of Ultrasound Guided Low Epidural Catheter Placement With Standard Epidural Catheter Placement

Randomized Controlled Trial of Virtual Reality

A Polypill for Acute Coronary Syndrome

Creatine Supplementation and Resistance Training to Preserve Muscle Mass and Attenuate Cancer Progression

Hypnotic Cognitive Therapy Reduce Acute & Chronic SCI Pain in Inpatient Rehabilitation

Treatment to Regress to Normoglycemia in Women with a Recent History of GDM

Reducing Hopelessness Through Improved Physical Activity in Adults With Heart Disease: With COVID-19 Considerations

Vacant Lot Greening and Violence-Related Outcomes

Antibiotic Therapy After Incision and Drainage for Abscess

Efficacy of Tranexamic Acid for Reducing Blood Loss and Blood Transfusion After Periacetabular Osteotomy

Randomized Trial of Healthy Family Foundations

TearCare MGX™ System With and Without Warming Hold

Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors

Post-Surgical Stereotactic Radiotherapy (SRT) Versus GammaTile-ROADS (Radiation One and Done Study)

A Community Health Worker Home Intervention to Improve Pediatric Asthma Outcomes